220 related articles for article (PubMed ID: 36087088)
41. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
42. Laparoscopic surgery for gastric cancer: where are we now and where are we going?
Huang L; Li TJ
Expert Rev Anticancer Ther; 2018 Nov; 18(11):1145-1157. PubMed ID: 30187785
[TBL] [Abstract][Full Text] [Related]
43. Insights into next developments in advanced gastric cancer.
Obermannová R; Lordick F
Curr Opin Oncol; 2016 Jul; 28(4):367-75. PubMed ID: 27092990
[TBL] [Abstract][Full Text] [Related]
44. Does Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery?
Johung KL; Stein SM
J Natl Compr Canc Netw; 2018 Aug; 16(8):1027-1028. PubMed ID: 30099377
[No Abstract] [Full Text] [Related]
45. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
[TBL] [Abstract][Full Text] [Related]
46. [Current status and research progress of perioperative chemotherapy in advanced gastric cancer].
Liu N; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):983-5. PubMed ID: 26499140
[TBL] [Abstract][Full Text] [Related]
47. Moxibustion for the side effects of surgical therapy and chemotherapy in patients with gastric cancer: A protocol for systematic review and meta-analysis.
Li S; Chen J; Wang Y; Zhou X; Zhu W
Medicine (Baltimore); 2020 Jul; 99(29):e21087. PubMed ID: 32702853
[TBL] [Abstract][Full Text] [Related]
48. Minimally Invasive Gastric Surgery.
Herrera-Almario G; Strong VE
Ann Surg Oncol; 2016 Nov; 23(12):3792-3797. PubMed ID: 27489058
[TBL] [Abstract][Full Text] [Related]
49. Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials.
Lei X; Wang Y; Shan F; Li S; Jia Y; Miao R; Xue K; Li Z; Ji J; Li Z
World J Surg Oncol; 2022 Dec; 20(1):405. PubMed ID: 36566193
[TBL] [Abstract][Full Text] [Related]
50. Effect of hyperthermic intraperitoneal chemotherapy for gastric cancer patients: a meta-analysis of the randomized controlled trials.
Liu YW; Du Y; Chen BA
J Int Med Res; 2019 Dec; 47(12):5926-5936. PubMed ID: 31741406
[TBL] [Abstract][Full Text] [Related]
51. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials.
Hu JK; Chen ZX; Zhou ZG; Zhang B; Tian J; Chen JP; Wang L; Wang CH; Chen HY; Li YP
World J Gastroenterol; 2002 Dec; 8(6):1023-8. PubMed ID: 12439918
[TBL] [Abstract][Full Text] [Related]
52. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
[TBL] [Abstract][Full Text] [Related]
53. Medical management of gastric cancer: a 2017 update.
Charalampakis N; Economopoulou P; Kotsantis I; Tolia M; Schizas D; Liakakos T; Elimova E; Ajani JA; Psyrri A
Cancer Med; 2018 Jan; 7(1):123-133. PubMed ID: 29239137
[TBL] [Abstract][Full Text] [Related]
54. Management of single brain metastasis: a practice guideline.
Mintz A; Perry J; Spithoff K; Chambers A; Laperriere N
Curr Oncol; 2007 Aug; 14(4):131-43. PubMed ID: 17710205
[TBL] [Abstract][Full Text] [Related]
55. The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.
Chau I; Norman AR; Cunningham D; Oates J; Hawkins R; Iveson T; Nicolson M; Harper P; Seymour M; Hickish T
Ann Oncol; 2009 May; 20(5):885-91. PubMed ID: 19164454
[TBL] [Abstract][Full Text] [Related]
56. Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.
Kim YI; Cho SJ; Lee JY; Kim CG; Kook MC; Ryu KW; Kim YW; Choi IJ
Cancer Res Treat; 2016 Jul; 48(3):1020-9. PubMed ID: 26582396
[TBL] [Abstract][Full Text] [Related]
57. Nutritional Support Indications in Gastroesophageal Cancer Patients: From Perioperative to Palliative Systemic Therapy. A Comprehensive Review of the Last Decade.
Mulazzani GEG; Corti F; Della Valle S; Di Bartolomeo M
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444926
[TBL] [Abstract][Full Text] [Related]
58. Chinese herbal medicines for induction of remission in advanced or late gastric cancer.
Yang J; Zhu L; Wu Z; Wang Y
Cochrane Database Syst Rev; 2013 Apr; (4):CD005096. PubMed ID: 23633324
[TBL] [Abstract][Full Text] [Related]
59. Early gastric cancer in the remnant stomach.
Takeda J; Toyonaga A; Koufuji K; Kodama I; Aoyagi K; Yano S; Ohta J; Shirozu K
Hepatogastroenterology; 1998; 45(23):1907-11. PubMed ID: 9840174
[TBL] [Abstract][Full Text] [Related]
60. Effects of perioperative enhanced recovery after surgery pathway management versus traditional management on the clinical outcomes of laparoscopic-assisted radical resection of distal gastric cancer: study protocol for a randomized controlled trial.
Tian Y; Cao S; Li L; He Q; Xia L; Jiang L; Ding Y; Wang X; Wang H; Mao W; Hui X; Shi Y; Zhang H; Chu X; Kehlet H; Zhou Y
Trials; 2020 May; 21(1):369. PubMed ID: 32357913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
